Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Cash from Investing Activities (2016 - 2025)

OptimizeRx's Cash from Investing Activities history spans 16 years, with the latest figure at -$10000.0 for Q3 2025.

  • For Q3 2025, Cash from Investing Activities rose 89.13% year-over-year to -$10000.0; the TTM value through Sep 2025 reached -$258000.0, up 99.02%, while the annual FY2024 figure was -$450000.0, 98.22% up from the prior year.
  • Cash from Investing Activities for Q3 2025 was -$10000.0 at OptimizeRx, up from -$44000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $3.2 million in Q2 2023 and bottomed at -$37.5 million in Q3 2022.
  • The 5-year median for Cash from Investing Activities is -$120000.0 (2024), against an average of -$4.5 million.
  • The largest annual shift saw Cash from Investing Activities crashed 22425.43% in 2022 before it skyrocketed 252.02% in 2023.
  • A 5-year view of Cash from Investing Activities shows it stood at -$99021.0 in 2021, then plummeted by 18567.26% to -$18.5 million in 2022, then plummeted by 40.66% to -$26.0 million in 2023, then skyrocketed by 99.54% to -$120000.0 in 2024, then skyrocketed by 91.67% to -$10000.0 in 2025.
  • Per Business Quant, the three most recent readings for OPRX's Cash from Investing Activities are -$10000.0 (Q3 2025), -$44000.0 (Q2 2025), and -$84000.0 (Q1 2025).